Close

Orphazyme A/S: Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Orphazymes' shares

Company announcement Orphazyme A/S
No. 9/2017 Ole Maaløes Vej 3
  DK-2200 Copenhagen N
   
  www.orphazyme.com
  Company Registration No. 32266355
   
  16 November 2017

Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 ("Orphazyme"), hereby notifies receipt of information of the following transactions made by persons discharging managerial responsibilities in Orphazyme and persons closely associated with them in Orphazymes' shares in connection with the Initial Public Offering:

1 Details of the Reporting Person / Closely Associated Person
a) Name Georges Gemayel
2 Reason for the notification
a) Position/status Chairman of the Board of Directors
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060910917
b) Nature of the transaction Exercise of warrants for shares
c) Price(s) and volume(s) Price (s) Volume(s)
1.00 87,758
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Bo Jesper Hansen
2 Reason for the notification
a) Position/status Deputy Chairman of the Board of Directors
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060910917
b) Nature of the transaction Exercise of warrants for shares
c) Price(s) and volume(s) Price (s) Volume(s)
1.00 29,445
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Bo Jesper Hansen
2 Reason for the notification
a) Position/status Deputy Chairman of the Board of Directors
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 50,000
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Bohrs Tower IVS
2 Reason for the notification
a) Position/status Closely Associated Person to Martin Bonde, member of the board of directors
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060910917
b) Nature of the transaction Exercise of warrants for shares
c) Price(s) and volume(s) Price (s) Volume(s)
1.00 42,884
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Martin Bonde
2 Reason for the notification
a) Position/status Member of the Board of Directors
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 3,125
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Rahbek Kornum IVS
2 Reason for the notification
a) Position/status Closely Associated Person to Martin Rahbek Kornum, member of the Board of Directors (resigned 16 November 2017)
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060910917
b) Nature of the transaction Exercise of warrants for shares
c) Price(s) and volume(s) Price (s) Volume(s)
1.00 22,726
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Catherine Moukheibir
2 Reason for the notification
a) Position/status Member of the Board of Directors
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 7,980
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Anders Hedegaard
2 Reason for the notification
a) Position/status Member of the Board of Directors
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 6,250
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Kurma Biofund II
2 Reason for the notification
a) Position/status Closely Associated Person to Rémi Droller, member of the Board of Directors
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 139,578
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name LSP V Cöoperatieve U.A.
2 Reason for the notification
a) Position/status Closely Associated Person to Martijn Kleijwegt, member of the Board of Directors
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 279,157
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name WoB Holding IVS
2 Reason for the notification
a) Position/status Closely Associated Person to Anders Hinsby, Chief Executive Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares 
ISIN DK0060910917
b) Nature of the transaction Exercise of warrants for shares
c) Price(s) and volume(s) Price (s) Volume(s)
1.00 180,846
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Anders Hinsby
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 5,000
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Alpha Healthcare Investments ApS
2 Reason for the notification
a) Position/status Closely Associated Person to Anders Vadsholt, Chief Financial Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060910917
b) Nature of the transaction Exercise of warrants for shares
c) Price(s) and volume(s) Price (s) Volume(s)
1.00 121,556
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Anders Vadsholt
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 6,250
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Dare to Dream IVS
2 Reason for the notification
a) Position/status Closely Associated Person to Thomas Kirkegaard Jensen, Chief Scientific Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060910917
b) Nature of the transaction Exercise of warrants for shares
c) Price(s) and volume(s) Price (s) Volume(s)
1.00 156,535
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Thomas Kirkegaard Jensen
2 Reason for the notification
a) Position/status Chief Scientific Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 4,000
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Thomas Blaettler
2 Reason for the notification
a) Position/status Chief Medical Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060910917
b) Nature of the transaction Exercise of warrants for shares
c) Price(s) and volume(s) Price (s) Volume(s)
1.00 108,502
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

1 Details of the Reporting Person / Closely Associated Person
a) Name Thomas Blaettler
2 Reason for the notification
a) Position/status Chief Medical Officer
b) Initial notification/Amendment Initial notification
3 Details of the Company, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Orphazyme A/S
b) LEI code 54930025OZD2GGSQ7L42
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument and identification code Shares  

ISIN DK0060911055
b) Nature of the transaction Subscription for shares
c) Price(s) and volume(s) Price (s) Volume(s)
80.00 1,875
d) Aggregated information
  • Aggregated volume
  • Price
 
e) Date of the transaction 2017-11-16 09:00 UTC+1
f) Place of the transaction Nasdaq Copenhagen A/S - XCSE

For additional information, please contact   
Orphazyme  
Anders Vadsholt, CFO +45 28 98 90 55
Orphazyme A/S - Reporting of transactions



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Orphazyme A/S via Globenewswire

Attachments

Orphazyme A/S - Reporting of transactions